FMCSA action against 2 doctors threatens licenses of over 15,000 truckers
WASHINGTON — The Federal Motor Carrier Safety Administration has voided thousands of medical examiner certificates issued by two Houston-area doctors, putting the livelihoods of over 15,000 commercial drivers at risk.
A 'high volume' of physical examinations performed by Dr. Jenny Le (Medical Examiner National Registry No. 4762579227) and Dr. Dustin Mai (National Registry No. 7120983977) between March 2023 and March 2025 raised red flags at FMCSA, which referred the matter to the Transportation Department's Office of Inspector General, according to the agency.
DOT subsequently collaborated with the FBI and the Homeland Security Department for further investigation, after which FMCSA found that Drs. Le and Mai 'failed to correctly apply required standards in determining that drivers are physically qualified to operate a CMV (commercial motor vehicle).'
On Thursday, FMCSA voided 'over 15,000 unexpired Medical Examiner's Certificates (MECs) issued by Dr. Le and Dr. Mai between March 2023 and March 2025 – an action that affected 15,225 commercial motor vehicle drivers,' the agency announced on Friday.FMCSA stated that while the decision does not immediately make an affected driver unqualified to drive a truck, drivers who received their MECs from the two medical examiners must get a new certificate by May 10 from an active medical examiner listed on the National Registry.
FMCSA warned, however, that 'if a driver fails to obtain a new certificate by the identified date, the driver's respective state drivers licensing agency (SDLA) will initiate procedures to downgrade the driver's CDL.'
'FMCSA's primary mission is to enhance safety on our nation's roadways,' said FMCSA Chief Counsel Jesse Elison, the effective leader of the agency while it awaits formal confirmation of an administrator.
'Removing non-compliant medical examiners from the National Registry is a necessary step to maintain the integrity of the medical certification process and ensure that only qualified, properly trained professionals are certifying the physical qualifications of commercial motor vehicle drivers.'780,000 driver medical exams could be missing from FMCSA database
How do trucking medical examiners stay certified?
FMCSA updates guidance for truck driver medical examiners
Click for more FreightWaves articles by John Gallagher.
The post FMCSA action against 2 doctors threatens licenses of over 15,000 truckers appeared first on FreightWaves.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
3 hours ago
- Yahoo
New Mexico Delegation to Promote the State's Bioscience Industry at BIO International Convention in Boston
Delegates from public, private, and higher education entities will participate in the New Mexico Pavilion to create new connections and drive interest in the state's bioscience industry Albuquerque, NM, June 11, 2025 (GLOBE NEWSWIRE) -- A delegation of government, economic development, association and industry leaders and businesses will represent the New Mexico bioscience industry at the BIO International Convention in Boston June 16-19. The Albuquerque Regional Economic Alliance (AREA) will promote the New Mexico bioscience industry, learn about the latest bioscience trends, and connect with companies interested in relocating or expanding their business in greater Albuquerque. 'The greater Albuquerque region has a growing number of bioscience assets and workforce clusters that make it a prime location for medical technology companies,' said AREA President & CEO Danielle Casey. 'This conference gives us an opportunity to highlight assets driving that growth, to understand how to best support our local firms and to see how trends and technology are shaping site location and expansion decisions.' Representatives from AREA will exhibit at the conference with partners from Presbyterian Health, UNM Health Sciences, the New Mexico Bioscience Authority, Sandoval Economic Alliance, the New Mexico Economic Development Department, Tricore, Los Alamos National Labs. The City of Albuquerque, Bernalillo County and Sandoval County are also serving as sponsors of this effort. Each partner will highlight different aspects of the bioscience industry, which is broadly defined as any science that deals with the biological aspects of living organisms, by showcasing their respective organizations. 'Bernalillo County is ready and eager to partner with biotechnology businesses looking to expand in central New Mexico,' said Marcos Gonzales, Executive Development Officer for Bernalillo County. 'The I-40 TradePort Corridor is a key asset for companies seeking to integrate national or regional logistics and distribution capabilities into their growth strategies. If your expansion plans include logistics automation or multi-modal connectivity, we're here to find the right solution together.' 'The University of New Mexico Health Sciences Office of Research is honored to participate in the 2025 BIO International Convention,' said Dr. Hengameh Raissy, Vice President of Research at UNM Health Sciences. 'As part of the New Mexico booth, our team is eager to showcase groundbreaking research, build strategic partnerships, and explore new opportunities for collaboration that drive advancements in health and biomedical sciences. We are excited to engage with global leaders in biotechnology and life sciences, and to highlight the impactful work taking place at UNM Health Sciences and throughout New Mexico.' A featured and exciting showcase will occur on Tuesday, June 17 during the main exhibit hall reception, courtesy of Visit Albuquerque, where booth visitors will experience the thrill of a hot air balloon ride from the safety of the ground through virtual reality. The region has seen consistent growth within the industry, thanks to high concentrations of technical occupations, key regional assets like national laboratories and top-tier research universities, and a statewide talent pipeline of STEM-based graduates that has seen steady growth over the past five years. Overall, the state of New Mexico has seen a 26% job growth increase in the past five years in the bioscience cluster and 3,970 Statewide STEM Graduates. 'Albuquerque offers the innovation ecosystem, workforce, and infrastructure needed to help bioscience companies thrive and scale,' said Economic Development Director Max Gruner. 'We're committed to meeting businesses where they are and building new partnerships.' The BIO International Convention is the largest and most comprehensive event for biotechnology, representing the full ecosystem of biotech with over 20,000 industry leaders from across the globe. It is regarded as one of the most significant gatherings in the industry, providing a platform for New Mexico to connect and make strategic connections with investors, businesses interested in their research or products, and industry leaders from the pharmaceutical, med tech, life science, health care, government, and academic institutions. The Exhibition showcases over 500 exhibitors offering cutting-edge solutions in product development, contract research, contract manufacturing, and beyond, providing the New Mexico bioindustry an opportunity to build new partnerships and increase visibility and brand awareness of New Mexico as a leading location to do business. To view the New Mexico delegation's schedule of booth events and representatives, as well as reports and data on the bioscience industry in New Mexico, visit For more information about the conference, visit: About AREAThe Albuquerque Regional Economic Alliance is a 501(c)(3) nonprofit organization whose mission is to lead and execute strategies designed to grow and diversify the economic base of the greater Albuquerque region, creating a prosperous, diverse and inclusive economy and elevating the standard of living for all. AREA provides confidential assistance to businesses considering the area for expansion and new investment. Since its creation in 1960, AREA has recruited more than 250 companies and more than 35,000 jobs to the Albuquerque metro area. AREA also provides retention and expansion assistance to existing industry. For more information, visit CONTACT: Danielle Casey Albuquerque Regional Economic Alliance 505-705-3785 dcasey@
Associated Press
10 hours ago
- Associated Press
Kemimoto Celebrates 14 Years of Powersports Innovation with Anniversary Mega Sale
Houston, TX, Texas, United States, June 11, 2025 -- Kemimoto, a trusted leader in UTV accessories and motorcycle gear, is celebrating its 14th anniversary with a major month-long sales event designed for outdoor enthusiasts and off-road riders. From June 5 to June 30, the Kemimoto 14th Anniversary Sale delivers deep discounts, sitewide deals, and exclusive bundles on high-performance gear built for adventure. For over a decade, Kemimoto has specialized in durable, rider-tested off-road accessories for UTVs, ATVs, and motorcycles, supporting top vehicle brands including Polaris, Can-Am, Honda, CFMOTO, and more. The brand is recognized for its commitment to functional design, rugged reliability, and community-driven innovation. 'We're proud to celebrate 14 years of riding alongside our customers,' said a Kemimoto spokesperson. 'From sand dunes to snow trails, Kemimoto has always been about enabling more confident, comfortable, and exciting rides.' Anniversary Event Highlights: June 5–30 1. Up to 45% OFF: Save on popular UTV upgrades like sound bars, mirrors, storage bags, and more. 2. Extra 14% OFF Sitewide (Code: EXTRA14): No minimum required — stackable with sale items. 3. Clearance Boost – Extra 20% OFF (Code: MCL20): Get even deeper savings on end-of-line gear. 4. New Subscribers Get 15% OFF: First-time customers can unlock additional savings instantly. Top Powersports Accessories Featured Kemimoto's most in-demand products will be featured throughout the sale, including: 1. Universal UTV Sound Bars – Weatherproof, Bluetooth-enabled, and trail-tested audio for every terrain. 2. UTV Side Mirrors – Wide-angle visibility, tough housing, and easy installation for most models. 3. LED Whip Lights – Illuminate night rides, sand dunes, and parades with vibrant, customizable lights. 4. Model-Specific Gear – Fit-tested accessories for Polaris RZR / Ranger / General, Can-Am Maverick X3 / Defender, CFMOTO ZForce / UForce, and Honda Pioneer / Talon. 5. Motorcycle Accessories – Tactical gloves, heated gear, handlebar mirrors, and storage kits built for two-wheeled adventure. Join the Celebration Kemimoto's 14th Anniversary is more than a sale — it's a thank-you to the community that powers the journey. With unbeatable pricing, exclusive codes, and free subscriber perks, now is the perfect time to upgrade your rig and stock up for the next adventure. Shop the Anniversary Event at About the company: Complete Journey of Dream Contact Info: Name: Kemimoto Email: Send Email Organization: Kemimoto Website: Release ID: 89162123 Should any errors, concerns, or inconsistencies arise from the content provided in this press release that require attention or if a press release needs to be taken down, we kindly request that you immediately contact us at [email protected] (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our efficient team will be at your disposal for timely assistance within 8 hours – taking necessary measures to rectify identified issues or providing guidance on the removal process. We prioritize delivering accurate and reliable information.
Medscape
14 hours ago
- Medscape
Mailed Kits Beat Office Visits for Cervical Cancer Screening
Mailed self-collection kits and a telephone reminder helped increase cervical cancer screening (CCS) rates more than twice as much as telephone reminders for an office visit, according to new data from a randomized clinical trial in a safety-net population. The home kits paired with additional patient contact increased numbers even further. In a trial that included 2474 people overdue for CCS (94% of them from minority populations), participants randomized to a telephone reminder with a mailed self-collection kit had 41.1% participation compared to those with a phone reminder to come in for an office visit (17.4%). CCS rates were modestly higher (46.6%) when people received contact in addition to the telephone reminder and mailed self-collection kit for testing human papillomavirus (HPV). Self-collection with additional patient contact was designed to be different from self-collection with a telephone reminder in terms of the dose of patient interactions rather than content, minimizing potential contamination across the self-collection with telephone reminder and self-collection with additional patient contact groups. The study, led by Jane R. Montealegre, PhD, with the Department of Behavioral Science, The University of Texas MD Anderson Cancer Center in Houston, was conducted from February 20, 2020, to August 31, 2023, and published in JAMA Internal Medicine . Cervical Cancer Could be Eliminated in the US in 10-20 Years Estimates show that cervical cancer in the US could see national-level elimination in the next one to two decades if CCS rates hit 90%. However up-to-date screening has declined in recent years and was 75.2% in 2021, with rates notably lower among underserved populations, including women and people with a cervix who are uninsured or publicly insured, live in rural areas, and are from minority populations. The study researchers noted that the results in this trial, the PRESTIS trial, are consistent with the relative participation rates of previous trials. In a recent meta-analysis of 28 trials, Stefanie Costa and colleagues reported a 2.5-fold higher participation in screening with mailed self-collection vs usual care. 'Notably distinct from previous trials are the large screening proportions attained in the [self-collection (SC) group] (41.1%) and SC with patient navigation (46.6%) groups, as compared to the global estimate of 24% reported in the meta-analysis,' the authors wrote. In an accompanying editorial, Eve Rittenberg, MD, MA, with the Division of Women's Health, Brigham and Women's Hospital and Harvard Medical School in Boston, and colleagues wrote that home self-collection 'has the potential to meaningfully reduce cervical cancer burden, especially among underserved populations.' They pointed out that self-collection has previously been studied in a clinical setting, where women can collect a sample privately without undergoing an invasive Pap smear and that 'self-collected HPV samples have similar specificity and sensitivity to clinician-collected samples.' But it hasn't been known whether the tests need to be performed in a clinic. Home Screening May Further Eliminate Barriers Montealegre's team shows that 'home self-collection demonstrates that people can adequately obtain usable samples in the privacy of their homes, as only 6% of samples were deemed inadequate for evaluation,' the editorialists wrote. Home-based screening, they explained, may further eliminate screening barriers for underserved populations with lower costs and fewer logistical hurdles. Additionally, screening via pelvic exam can be uncomfortable and may be culturally unacceptable for some. Pelvic exam-based screening may be particularly distressing to those who have experienced sexual trauma, they wrote. They pointed out that options for CCS are growing with the approval last month by the FDA of a home HPV self-collection kit, which will be available for clinical use within months. Self-collection of HPV samples is included in the World Health Organization's global strategy to eliminate cervical cancer by 2030, and the draft US Preventive Services Task Force CCS guidance now includes self-collection as an option. Future research should help determine whether more home self-collected HPV screening leads to higher rates of treating precancerous lesions and eventually lower cervical cancer rates, the editorialists wrote. They also noted that efforts to increase CCS rates should be accompanied by efforts to increase HPV vaccination rates. The research was funded through grants from the National Institute on Minority Health and Health Disparities and the National Cancer Institute through an MD Anderson Cancer Center Support Grant, the Dan L Duncan Comprehensive Cancer Center Support Grant, and the Hollings Cancer Center Support Grant. The authors reported having no relevant financial relationships. An editorialist, Cary Gross, MD, reported receiving grants from Johnson & Johnson and the National Comprehensive Cancer Network (with funding provided by AstraZeneca) outside the submitted work. No other disclosures were reported.
